%20V2.jpg)
The Bellcast
Bridge the investing and markets knowledge gap with the Bell Direct Bellcast. From bite-size thought snippets, to full length interviews with the top executives of leading ASX200 companies, you'll be informed and ready for any market movement.
The Bellcast
From the helm: Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma's (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
- (0:56) A brief overview of Starpharma
- (2:31) Growing distribution network for Viraleze
- (3:29) SPL's exciting oncology portfolio and key partnerships with major companies
- (4:56) How Viraleze works and the market opportunity going forward
- (6:09) What's coming up next for SPL